Dinitrochlorobenzene treatment of condylomata acuminata.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0135232 Publication Model: Print Cited Medium: Print ISSN: 0004-8380 (Print) Linking ISSN: 00048380 NLM ISO Abbreviation: Australas J Dermatol Subsets: MEDLINE
    • Publication Information:
      Publication: New South Wales : Wiley-Blackwell
      Original Publication: [Sydney] Australasian College of Dermatologists.
    • Subject Terms:
      Anus Neoplasms/*drug therapy ; Condylomata Acuminata/*drug therapy ; Dinitrochlorobenzene/*therapeutic use ; Penile Neoplasms/*drug therapy; Adult ; Dinitrochlorobenzene/adverse effects ; Humans ; Male
    • Abstract:
      Fifteen patients with treatment-resistant condylomata acuminata have been treated by application of Dinitrochlorobenzene (DNCB). The agent was applied weekly as a 0.5 or 1% solution in acetone for a period of 6 to 8 weeks. Patients were sensitised 15 days before the onset of treatment by applying a 2% DNCB solution on the right arm in a quantity of 0.15 ml. In one patient treatment had to be stopped because of local irritation and one discontinued treatment. In the other 13 patients all lesions cleared completely. Patients were followed up for a year and no recurrence has appeared as yet. DNCB seems to be useful agent for treatment-resistant condylomata acuminata and justifies further clinical trials.
    • Accession Number:
      0 (Dinitrochlorobenzene)
    • Publication Date:
      Date Created: 19890101 Date Completed: 19910108 Latest Revision: 20201209
    • Publication Date:
      20231215
    • Accession Number:
      10.1111/j.1440-0960.1989.tb00430.x
    • Accession Number:
      2486168